STEADFAST GROUP LIMITED (SDF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SDF - STEADFAST GROUP LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: 2.82
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Steadfast Group is an insurance broker and underwriting group operating in Australia, New Zealand, Europe and Asia. Founded in 1996 the company listed on the ASX in 2013.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.29

19 Jul
2024

-0.060

OPEN

$6.29

-0.94%

HIGH

$6.31

1,867,780

LOW

$6.24

TARGET
$6.63 5.4% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . NOL . PSI . QBE . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
SDF: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx 18.5 26.6 xxx
DPS (cps) xxx 15.0 17.7 xxx
EPS Growth xxx 3.2% 44.2% xxx
DPS Growth xxx 15.4% 17.8% xxx
PE Ratio xxx N/A 23.6 xxx
Dividend Yield xxx N/A 2.8% xxx
Div Pay Ratio(%) xxx 81.3% 66.4% xxx

Dividend yield today if purchased 3 years ago: 3.39%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.38

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/03 - ex-div 6.75c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx18.5
DPS All xxxxxxxxxxxxxxx15.0
Sales/Revenue xxxxxxxxxxxxxxx1,388.5 M
Book Value Per Share xxxxxxxxxxxxxxx197.2
Net Operating Cash Flow xxxxxxxxxxxxxxx425.2 M
Net Profit Margin xxxxxxxxxxxxxxx13.63 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx10.16 %
Return on Invested Capital xxxxxxxxxxxxxxx6.79 %
Return on Assets xxxxxxxxxxxxxxx4.27 %
Return on Equity xxxxxxxxxxxxxxx10.16 %
Return on Total Capital xxxxxxxxxxxxxxx9.27 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx282.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx70 M
Long Term Debt xxxxxxxxxxxxxxx968 M
Total Debt xxxxxxxxxxxxxxx1,037 M
Goodwill - Gross xxxxxxxxxxxxxxx2,053 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,139 M
Price To Book Value xxxxxxxxxxxxxxx3.04

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx16.2 M
Capex % of Sales xxxxxxxxxxxxxxx1.17 %
Cost of Goods Sold xxxxxxxxxxxxxxx562 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx547 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx42 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

25/06/2024

1

Buy

$6.70

6.52%

Post the Steadfast Group investor day, UBS highlights the company’s growth outlook remains intact, with at least a decade of domestic M&A potential.

The analyst dismisses the market concerns about a shrinking acquisition runway with management pointing to a further circa $435m in accretive earnings domestically via M&A, equating to around 80% of the current profit base. 

The US expansion is progressing slower than expected, with management focusing on the US$6bn insurance market

UBS has lifted FY24/FY25 EPS forecasts by 1-2%, reflecting upgraded FY24 guidance and further investment potential in FY25. 

Buy rating and $6.70 target unchanged.

FORECAST
UBS forecasts a full year FY24 dividend of 18.00 cents and EPS of 28.00 cents.
UBS forecasts a full year FY25 dividend of 18.00 cents and EPS of 29.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXPERT VIEWS
Display All Commentary

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

08/04/2024

3

Neutral

$6.10

-3.02%

Global equity markets have posted a second consecutive quarter of outsized returns, underpinning positive March quarter mark-to-market investment gains across Jarden's insurance coverage universe.

The broker suggests general insurer earnings should be further supported by CAT budget beats over the quarter, particularly for the domestic general insurers, which are now past their peak exposure period.

Overall, Jarden prefer general insurer exposures over private health insurers and brokers, with Buy-rated QBE Insurance the top pick.

In the broker category, the $6.10 target and Neutral rating are maintained for Steadfast Group.

FORECAST
Jarden forecasts a full year FY24 dividend of 18.20 cents and EPS of 27.30 cents.
Jarden forecasts a full year FY25 dividend of 20.10 cents and EPS of 29.30 cents.

SDF STOCK CHART